Literature DB >> 182000

Systemic to pulmonary venous communication in the superior vena caval syndrome.

E S Wilson.   

Abstract

A case of superior vena caval obstruction due to bronchogenic carcinoma is presented. Upper extremity venography demonstrated shunting of contrast media from systemic veins to the right pulmonary veins. This collateral pathway has been previously described in the superior vena caval syndrome. A proposed mechanism for this flow pattern is discussed.

Entities:  

Mesh:

Year:  1976        PMID: 182000     DOI: 10.2214/ajr.127.2.247

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Vertebral body enhancement mimicking sclerotic osseous lesions in the setting of bilateral brachiocephalic vein thrombosis.

Authors:  Daniela Berritto; Salim Abboud; Christos Kosmas; Daniel Riherd; Mark Robbin
Journal:  Skeletal Radiol       Date:  2014-11-26       Impact factor: 2.199

2.  Vanishing bone metastases--a pitfall in the interpretation of contrast enhanced CT in patients with superior vena cava obstruction.

Authors:  N Thomas; T B Oliver; T Sudarshan
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

3.  Contrast-enhanced fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography in mediastinal T-cell lymphoma with superior vena cava syndrome.

Authors:  Sampath Santhosh; Arun Kumar Reddy Gorla; Anish Bhattacharya; Subhash Chander Varma; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2016 Jan-Mar

4.  Hypoxemia and Right-to-Left-Shunt in Patient with Antiphospholipid Syndrome: A Case Report with Multimodality Imaging Findings and Literature Review.

Authors:  Mnahi Bin Saeedan; Mashael Alrujaib; Ahmed L Fathala
Journal:  Case Rep Radiol       Date:  2016-02-29

5.  Vanishing bone metastases: a pitfall in contrast-enhanced CT in patients with venous thrombosis.

Authors:  R Pruente; C D Strickland; P J Koo
Journal:  BJR Case Rep       Date:  2015-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.